Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety
A Randomized, Controlled, 6-month Study to Compare the Effects of Volume- and Pressure-guided Adjustments on Weight Loss and Satiety in Patients Implanted With the Swedish Adjustable Gastric Band
1 other identifier
interventional
51
2 countries
2
Brief Summary
The purpose of this protocol is to determine how band fill volumes that are based on intraband pressure readings can influence the comfortability of the band and to compare weight loss with this methodology to weight loss with the conventional approach recommended in existing product labeling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2009
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 14, 2009
CompletedFirst Posted
Study publicly available on registry
August 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedResults Posted
Study results publicly available
April 3, 2012
CompletedAugust 20, 2012
August 1, 2012
1.3 years
August 14, 2009
November 2, 2011
August 14, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent Excess Weight Change at Day 180
Percent Excess Weight Change will be calculated per subject as 100% times the difference between screening and Day 180 visit weight divided by the difference between screening weight and ideal body weight for a given sex and height of a subject. Excess weight is defined as the Screening Weight minus the ideal body weight. Ideal body weight is taken from the 1983 Metropolitan Life using the upper limit value of the medium frame range.
Screening to Day 180
Secondary Outcomes (2)
Mean Static Intraband Pressure at Day 180
Day 180
Rate of Weight Loss kg/wk at Day 180
Screening to Day 180
Study Arms (2)
Conventional Adjustment Group
ACTIVE COMPARATORSubject whose band adjustments will be made via conventional standard of care (e.g., volume, hunger).
Intraband Pressure Arm
ACTIVE COMPARATORSubjects whose band adjustments will be guided by intraband pressure readings.
Interventions
Intraband pressure will be measured by a pressure recording system.
Band adjustments will be made via conventional standard of care (e.g., volume, hunger).
Eligibility Criteria
You may qualify if:
- Able to comprehend, follow and give informed consent.
- Be at least 18 years of age at time of trial enrollment.
- Had a pre-implantation BMI between 35 and 55 kg/m2.
- Have received a SAGB VC implant 1) 30-60 days (and not undergone first band adjustment yet)prior to the date of enrollment.
- Willingness to be randomized to intraband-based or conventional adjustments
- Willingness to consent to monthly visits and possible measurements of intraband pressure (requiring access to the injection port).
- Willingness to undergo up to 7 band adjustments within the 6-month period of the study.
- Able to sit approximately at a 90 degree-angle, from the floor, for IBP measurements.
- Willingness to return to office visits around the same time of the first in-study adjustment (plus or minus 2 hours)
- Willingness to consent to a limited UGI series if the investigator suspects the presence of a band-related complication or if the intraband pressure recordings deviate from expected.
- Willingness to refrain from taking medications or supplements indicated for or known to induce weight loss.
You may not qualify if:
- Females currently known to be pregnant.
- Ongoing or unresolved band perforation or band leakage.
- Ongoing (unresolved) slippage, erosion, or pouch dilation.
- Documented esophageal dysmotility/dyskinesia.
- Ongoing (unresolved) port obstruction or tube kinking.
- Current injection port infection.
- History of band revision or replacement.
- Previously documented or ongoing esophageal dilatation.
- Any condition that, in the opinion of the Investigator, may jeopardize the subject's well-being or the soundness of this study.
- Current use of medications or supplements indicated for or known to induce weight loss at any point during the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Adelaide Bariatric Center
Bedford Park, South Australia, 5042, Australia
OB Klinika, a.s.
Prague, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael Schwiers Principal Biostatistician
- Organization
- Ethicon Endo-Surgery Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2009
First Posted
August 18, 2009
Study Start
July 1, 2009
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
August 20, 2012
Results First Posted
April 3, 2012
Record last verified: 2012-08